Disc Medicine, Inc. (IRON) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 11 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for IRON is $110.25, representing a +56.4% upside from the current price of $70.48. Price targets range from a low of $75.00 to a high of $153.00.
